Nuclear Localization of Cystatin B, the Cathepsin Inhibitor Implicated in Myoclonus Epilepsy (EPM1)

By Riccio M.   Di Giaimo R.   Pianetti S.   Palmieri P.P.   Melli M.   Santi S.  

Experimental Cell Research, Vol. 262, Iss. 2, 2001-01 ,pp. : 84-94

Elsevier

Access to resources Recommend Favorite

Identification of a novel protein interacting with laforin, the epm2a progressive myoclonus epilepsy gene product

By Ianzano L.   Zhao X.C.   Minassian B.A.   Scherer S.W.  

Genomics, Vol. 81, Iss. 6, 2003-06 ,pp. : 579-587

Elsevier

Access to resources Recommend Favorite

Severer Phenotype in Unverricht-Lundborg Disease (EPM1) Patients Compound Heterozygous for the Dodecamer Repeat Expansion and the c.202C>T Mutation in the CSTB Gene

By  

Neurodegenerative Diseases, Vol. 8, Iss. 6, 2011-07 ,pp. : 515-522

Karger

Access to resources Recommend Favorite

The Gene for Human U2 snRNP Auxiliary Factor Small 35-kDa Subunit (U2AF1) Maps to the Progressive Myoclonus Epilepsy (EPM1) Critical Region on Chromosome 21q22.3

By Lalioti M.D.   Gos A.   Green M.R.   Rossier C.   Morris M.A.   Antonarakis S.E.  

Genomics, Vol. 33, Iss. 2, 1996-04 ,pp. : 298-300

Academic Press

Access to resources Recommend Favorite

The NNP-1 Gene (D21S2056E), Which Encodes a Novel Nuclear Protein, Maps in Close Proximity to the Cystatin B Gene within the EPM1 and APECED Critical Region on 21q22.3

By Jansen E.   Meulemans S.M.P.   Orlans I.C.R.   van de Ven W.J.M.  

Genomics, Vol. 42, Iss. 2, 1997-06 ,pp. : 336-341

Academic Press

Access to resources Recommend Favorite